Research Alert
The drugs in the diabetes pipeline are extremely promising because of their impressive anti-hyperglycemic effects coupled with remarkable weight loss capabilities.
This review summarizes the main drugs currently under development for the treatment of type 1 and type 2 diabetes, highlighting their strengths and side effects.
RSS